![William Polvino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Polvino
Directeur/Membre du Conseil chez
SAB BIOTHERAPEUTICS, INC.
Fortune : - $ au 30/06/2026
Profil
William J.
Polvino is Chief Executive Officer & Director at Bridge Medicines LLC.
He is Director at SAB Sciences, Inc. since 2019.
He is Independent Director at SAB Biotherapeutics, Inc. since 2019.
Formerly, Dr. Polvino was President & Chief Executive Officer at Sapphire Therapeutics, Inc. from 2002 to 2009.
He was President & Chief Executive Officer at Veloxis Pharmaceuticals A from 2011 to 2015.
He was President & Chief Executive Officer at Helsinn Therapeutics (U.S.), Inc. He was Independent Director at Big Cypress Acquisition Corp.
He was Principal at Merck & Co., Inc. He was Vice President-Clinical Affairs at Innoviva, Inc. Education includes a doctorate from the University of Medicine & Dentistry of New Jersey and an undergraduate degree from Boston College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de William Polvino
| Sociétés | Poste | Début |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/10/2019 |
Bridge Medicines LLC
 Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Operates as a bio-technology firm that develops therapeutics for oncology, neuropsychiatry and rare diseases | Directeur Général | - |
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Directeur/Membre du Conseil | 01/01/2019 |
Anciens postes connus de William Polvino
| Sociétés | Poste | Fin |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Directeur Général | 10/12/2015 |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | President | 01/01/2009 |
| BIG CYPR | Directeur/Membre du Conseil | - |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Directeur Général | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Formation de William Polvino
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sapphire Therapeutics, Inc.
Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Health Technology |
Bridge Medicines LLC
Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Operates as a bio-technology firm that develops therapeutics for oncology, neuropsychiatry and rare diseases | Health Technology |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Health Technology |
Big Cypress Acquisition Corp.
 Big Cypress Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
